Literature DB >> 2477490

Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes.

Q J Sattentau1, J Arthos, K Deen, N Hanna, D Healey, P C Beverley, R Sweet, A Truneh.   

Abstract

The CD4 molecule, a differentiation marker expressed primarily by T lymphocytes, plays an important role in lymphocyte activation. CD4 is also the receptor for HIV. A number of recent studies have localized the high affinity binding site of the HIV envelope glycoprotein, gp120, to the NH2-terminal (V1) domain of CD4, a region with sequence and predicted structural homology with Ig kappa chain V domains (V kappa). In this report, we show that V1 bears structural similarities with V kappa regions through detailed epitope mapping of 26 CD4 mAbs. The binding sites of these mAbs were initially defined relative to one another by crossblocking analysis and were then localized to specific domains of CD4 in blocking studies with truncated, soluble CD4 proteins. The epitopes within the V1 domain were mapped in detail with a panel of 17 substitution mutants, and the specificities of several mAbs that appear to recognize very similar epitopes were examined in crossblocking studies with anti-idiotype antibodies. The location of the epitopes is consistent with a V kappa-like structure of V1. Most of the epitopes lie within regions of predicted exposed loops. A number of these epitopes span discontinuous residues in the linear sequence that lies in close proximity in an Ig fold. Alignment of CD4 V1 with the Ig V kappa chains places these epitopes within stretches corresponding to the complimentarity-determining regions. This epitope analysis is relevant for a vaccine strategy for HIV based on anti-idiotype antibodies to CD4 mAbs and for studies with CD4 antibodies on the role of CD4 in T lymphocyte activation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2477490      PMCID: PMC2189462          DOI: 10.1084/jem.170.4.1319

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  41 in total

1.  Interaction between CD4 and class II MHC molecules mediates cell adhesion.

Authors:  C Doyle; J L Strominger
Journal:  Nature       Date:  1987 Nov 19-25       Impact factor: 49.962

2.  The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family.

Authors:  P J Maddon; D R Littman; M Godfrey; D E Maddon; L Chess; R Axel
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

3.  Neutralisation of HIV isolates by anti-idiotypic antibodies which mimic the T4 (CD4) epitope: a potential AIDS vaccine.

Authors:  A G Dalgleish; B J Thomson; T C Chanh; M Malkovsky; R C Kennedy
Journal:  Lancet       Date:  1987-11-07       Impact factor: 79.321

4.  A soluble recombinant polypeptide comprising the amino-terminal half of the extracellular region of the CD4 molecule contains an active binding site for human immunodeficiency virus.

Authors:  E A Berger; T R Fuerst; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

5.  Signal transduction through CD4 receptors: stimulatory vs. inhibitory activity is regulated by CD4 proximity to the CD3/T cell receptor.

Authors:  J A Ledbetter; C H June; P S Rabinovitch; A Grossmann; T T Tsu; J B Imboden
Journal:  Eur J Immunol       Date:  1988-04       Impact factor: 5.532

6.  Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen.

Authors:  D Gay; P Maddon; R Sekaly; M A Talle; M Godfrey; E Long; G Goldstein; L Chess; R Axel; J Kappler
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

7.  Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees.

Authors:  S L Hu; P N Fultz; H M McClure; J W Eichberg; E K Thomas; J Zarling; M C Singhal; S G Kosowski; R B Swenson; D C Anderson
Journal:  Nature       Date:  1987 Aug 20-26       Impact factor: 49.962

8.  Thymus-dependent membrane antigens in man: inhibition of cell-mediated lympholysis by monoclonal antibodies to TH2 antigen.

Authors:  R L Evans; D W Wall; C D Platsoucas; F P Siegal; S M Fikrig; C M Testa; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

9.  Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein.

Authors:  B A Jameson; P E Rao; L I Kong; B H Hahn; G M Shaw; L E Hood; S B Kent
Journal:  Science       Date:  1988-06-03       Impact factor: 47.728

10.  Stimulation and proliferation of CD4+ peripheral blood T lymphocytes induced by an anti-CD4 monoclonal antibody.

Authors:  S Carrel; A Moretta; G Pantaleo; G Tambussi; P Isler; B Perussia; J C Cerottini
Journal:  Eur J Immunol       Date:  1988-03       Impact factor: 5.532

View more
  33 in total

1.  Crosslinked HIV-1 envelope-CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques.

Authors:  Timothy Fouts; Karla Godfrey; Kathryn Bobb; David Montefiori; Carl V Hanson; V S Kalyanaraman; Anthony DeVico; Ranajit Pal
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-21       Impact factor: 11.205

2.  Crystal structure of an HIV-binding recombinant fragment of human CD4.

Authors:  S E Ryu; P D Kwong; A Truneh; T G Porter; J Arthos; M Rosenberg; X P Dai; N H Xuong; R Axel; R W Sweet
Journal:  Nature       Date:  1990-11-29       Impact factor: 49.962

3.  Mutations in the D strand of the human CD4 V1 domain affect CD4 interactions with the human immunodeficiency virus envelope glycoprotein gp120 and HLA class II antigens similarly.

Authors:  D Piatier-Tonneau; L N Gastinel; G Moussy; B Bénichou; F Amblard; P Vaigot; C Auffray
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

4.  Neutralization of HIV-1 by redirection of natural antibodies.

Authors:  Maria F Perdomo; Michael Levi; Matti Sällberg; Anders Vahlne
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

5.  Molecular characteristics of recombinant human CD4 as deduced from polymorphic crystals.

Authors:  P D Kwong; S E Ryu; W A Hendrickson; R Axel; R M Sweet; G Folena-Wasserman; P Hensley; R W Sweet
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

6.  Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans.

Authors:  I Mondor; S Ugolini; Q J Sattentau
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

7.  Human colon epithelial cells productively infected with human immunodeficiency virus show impaired differentiation and altered secretion.

Authors:  J Fantini; N Yahi; S Baghdiguian; J C Chermann
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

8.  Functional epitope analysis of the human CD4 molecule: antibodies that inhibit human immunodeficiency virus type 1 gene expression bind to the immunoglobulin CDR3-like region of CD4.

Authors:  M Benkirane; M Hirn; D Carrière; C Devaux
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 9.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03

10.  A monoclonal antibody to the CDR-3 region of CD4 inhibits soluble CD4 binding to virions of human immunodeficiency virus type 1.

Authors:  J P Moore
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.